[White Paper/Infographic] The Changing Face of Global Clinical Trials: Asia-Pacific as an Ideal Destination for Specialty Biopharma
September 2017, A Frost & Sullivan White Paper
White Paper
Introduction
The contract research organization (CRO) market in the Asia-Pacific (APAC) region is the fastest- growing in the world, with revenue expected to increase at a 20% compound annual growth rate (CAGR) from 2016 to 2021 compared with the rest of the world’s 11.4% CAGR.
Table of Contents
- EXECUTIVE SUMMARY
- TRANSFORMATION UNDERWAY IN THE BIOPHARMA INDUSTRY
- SHIFT TO OUTSOURCING AND CROs
- APAC ON THE RISE
- WORKING WITH THE RIGHT DEVELOPMENT PARTNER: CMIC
- THE LAST WORD
Infographic
